zonisamide has been researched along with Kussmaul Aphasia in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Excerpt | Relevance | Reference |
---|---|---|
"Zonisamide was administered at age 6 years, which was effective against her seizures, but selective mutism, violent behaviour, and lack of concentration developed at age 10 years." | 1.31 | Selective mutism and obsessive compulsive disorders associated with zonisamide. ( Hirai, K; Jozaki, K; Kimiya, S; Kumagai, N; Seki, T; Tabata, K, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirai, K | 1 |
Kimiya, S | 1 |
Tabata, K | 1 |
Seki, T | 1 |
Jozaki, K | 1 |
Kumagai, N | 1 |
1 other study available for zonisamide and Kussmaul Aphasia
Article | Year |
---|---|
Selective mutism and obsessive compulsive disorders associated with zonisamide.
Topics: Adolescent; Anticonvulsants; Epilepsies, Partial; Female; Humans; Isoxazoles; Male; Mutism; Obsessiv | 2002 |